Radiation for Breast Cancer: 603 Real Stories

603 stories match breast cancer and radiation. 562 of them mention surgery.

Cancer Stories

A patient, who was diagnosed with Stage III Invasive Ductal CarcinomaBreast Cancer

Triple-negative breast cancer and ovarian cancer treated with chemotherapy and PARP inhibitor

Patient Info: Anonymized, Female, 40s | Stage III

Biomarkers: Germline pathogenic BRCA2 c.6468_6469del; breast tumor triple-negative

As of April 2024, 6-week follow-up after breast and nodal radiation was unremarkable, erythema had resolved, and no breast, chest wall, respiratory, or axillary abnormality was found; longer-term control was not reported.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Breast CancerBreast Cancer

Vision problems led to a breast cancer diagnosis (cancer-associated retinopathy)

Patient Info: Anonymized, Female

Biomarkers: Anti-recoverin and anti-alpha-enolase antibodies associated with cancer-associated retinopathy; tumor biomarkers not reported

Six years after her initial visual symptoms, vision remained stable and she remained cancer-free on surveillance.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

HER2-positive apocrine breast cancer: chemotherapy and Herceptin

Patient Info: Anonymized, Female, 60s

Biomarkers: HER2-positive; AR-positive; ER-negative; PR-negative

Disease-free for 2 years after treatment for HER2-positive apocrine breast cancer, with no reported lymph-node recurrence or distant metastases during surveillance.

PubMed Central
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Invasive lobular breast cancer with isolated scalp metastasis: excision and endocrine therapy

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: Original breast tumor: ER-positive; PR-positive; scalp metastasis: CK7-positive; ER-positive; GCDFP-15 partially positive

Metastatic Site: scalp/skin

As of April 2024, she had no signs of recurrence in the breast or scalp and no distant metastasis after excision of the isolated scalp metastasis while continuing anastrozole.

PubMed Central
OutcomeCancer-Free / NED
Catherine, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV Breast Cancer: Catherine's Survivor Story

Patient Info: Catherine, Female, 40s | Stage IV

Metastatic Site: Brain/cerebellum region

As of April 2024, Catherine said she had been in remission for almost 3 years after a 2019 metastatic recurrence near the cerebellum, while continuing preventive treatment.

YouTube (FR search)
OutcomeCancer-Free / NED
Dorian, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HR-Positive Invasive Ductal Carcinoma: Dorian's Survivor Story

Patient Info: Dorian de Salvo, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2-positive

As of March 2024, Dorian had a complete response to TCHP chemotherapy, clear surgical margins, and no lymph-node involvement after surgery, with radiation completed and additional care still expected for several months.

The Patient Story
OutcomeCancer-Free / NED
Loriana, who was diagnosed with Breast CancerBreast Cancer

Breast Cancer: Loriana's Survivor Story

Patient Info: Loriana, Female

Biomarkers: Breast cancer biomarkers not reported

As of February 2024, Loriana was surviving after AML and later breast cancer, while living with chronic pain, depression, PTSD, and a strong advocacy role focused on patient support and self-advocacy.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Debbie, who was diagnosed with Stage I Breast AdenocarcinomaBreast Cancer

Stage I Breast Adenocarcinoma: Debbie's Survivor Story

Patient Info: Debbie Wade, Female | Stage I

As of February 2024, Debbie was cancer-free after double mastectomy, 4 weeks of radiation therapy and DIEP flap reconstruction for Stage I mucinous adenocarcinoma of the left breast, with mild left-arm lymphedema as the only reported side effect.

MD Anderson
OutcomeCancer-Free / NED
Dena, who was diagnosed with Stage IV Breast CancerBreast Cancer

Stage IV BRCA Breast Cancer: Dena's Patient Story

Patient Info: Dena Ofengeim, Under 40 | Stage IV

Biomarkers: Hormone receptor-positive; BRCA mutation

Metastatic Site: spine

Dena improved rapidly after treatment, regained her mobility, returned to an active life, and remained on therapy for metastatic breast cancer.

Dana-Farber
OutcomeResponding Well
A patient, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Male Invasive Lobular Breast Cancer With a Pathogenic PALB2 Variant

Patient Info: Anonymized, male, 40s

Biomarkers: ER-positive; PR-positive; HER2 not amplified; pathogenic PALB2 variant

He was disease-free at 1-year follow-up after mastectomy, chemotherapy, and radiotherapy.

PubMed Central
OutcomeCancer-Free / NED
Sally, who was diagnosed with Invasive Lobular CarcinomaBreast Cancer

Invasive Lobular Carcinoma: Sally's Survivor Story

Patient Info: Sally Johnston, 70+

Biomarkers: Estrogen receptor-positive

Sally was in remission by the end of 2014 and remained active about 10 years after treatment.

Dana-Farber
OutcomeCancer-Free / NED
A patient, who was diagnosed with Breast CancerBreast Cancer

Aggressive breast cancer presenting with severe skin infection

Patient Info: Anonymized, Female

Biomarkers: ER 99% positive; PR 99% positive; HER2 1+ / negative; Ki-67 3%; grade 2; 3 interpectoral lymph nodes negative; later axillary-node biopsy benign

She recovered from sepsis and surgery, had no distant metastases and a benign axillary-node biopsy, and was receiving adjuvant radiation with anastrozole ongoing.

PubMed Central
OutcomeCare Ongoing
A patient, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage IIIA breast cancer history with benign lipid pneumonia mimicking lung malignancy

Patient Info: Anonymized, Female, 40s | Stage III

Prior Stage IIIA breast cancer treatment was completed; a later suspicious lung lesion proved to be benign lipid pneumonia rather than recurrence or lung cancer, and she was asymptomatic 1 year after lobectomy with continued surveillance for new right-lung changes.

PubMed Central
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage IV Invasive Ductal CarcinomaBreast Cancer

Metastatic HER2-Positive Breast Cancer With Treatment-Related Telangiectasias

Patient Info: Anonymized, female, 60s | Stage IV

Biomarkers: HER2-positive; initially ER-negative and PR-negative; metastatic disease weakly ER-positive and PR-negative; germline testing negative

Metastatic Site: left supraclavicular, mediastinal, axillary and…

Living with HER2-positive breast cancer for 9+ years since her 2014 diagnosis, including metastatic disease since 2017. She remained on reduced-dose tucatinib in 2023 while treatment-related telangiectasias improved after dose reduction and electrocautery.

PubMed Central
OutcomeLiving With Cancer
A patient, who was diagnosed with Stage IV Invasive Lobular CarcinomaBreast Cancer

Metastatic invasive lobular breast carcinoma to pancreas: biliary stent and paclitaxel

Patient Info: Anonymized, Female, 40s | Stage IV

Biomarkers: Primary breast tumor was triple-negative. Pancreatic metastasis was ER-positive/GATA-positive

Metastatic Site: pancreas; coelio-mesenteric lymph nodes

After 21 years of remission, she developed pancreatic and coelio-mesenteric nodal metastases from invasive lobular breast carcinoma; palliative paclitaxel was stopped after 2 courses because her condition deteriorated, and she was lost to follow-up.

PubMed Central
OutcomeSetback / Progression
Gail, who was diagnosed with Stage III Breast CancerBreast Cancer

Stage III Breast Cancer: Gail's Patient Story

Patient Info: Gail, Female, 60s | Stage III

Biomarkers: Luminal A

As of 2024, Gail had Stage III luminal A breast cancer and was awaiting the start of planned treatment with lumpectomy, radiation therapy, chemotherapy, and hormone therapy.

Our Cancer Stories
OutcomeCare Ongoing
Chantal, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Chantal's Survivor Story

Patient Info: Chantal, Female, Under 40 | Stage II

Biomarkers: Triple-negative breast cancer; BRCA1 mutation

As of December 2023, Chantal reported that she did not currently have cancer, was followed by medical oncology every 3-4 months, and used Signatera testing because tumor markers were not reliable for her.

The Patient Story
OutcomeCancer-Free / NED
A patient, who was diagnosed with Stage I Breast CancerBreast Cancer

Five Years Without Breast Cancer Recurrence Despite a Markedly Elevated CA 15-3

Patient Info: Anonymized, female, 70+ | Stage I

Biomarkers: ER-positive, PR-positive, HER2-positive

Five years after her Stage I breast-cancer diagnosis, breast imaging and systemic evaluation showed no evidence of recurrence. The markedly elevated CA 15-3 was traced to a separate renal tumor and normalized after nephrectomy.

PubMed Central
OutcomeCancer-Free / NED